After a slowdown in IPOs, M&A activity and financing in 2023, the biotech industry is showing early signs of recovery in 2024.

MM+M caught up with Klick Health chief creative officer Rich Levy and Pharma juror Roberta Raduan ahead of this year’s ...

During the covid-19 pandemic, federal lawmakers launched the Affordable Connectivity Program with the goal of connecting more people to their jobs, schools, and doctors.

Google is in hot water again over AI inaccuracies. With ads soon coming to its AI overviews search product, digital ...

The decision to spin off Grail came three years after Illumina bought the company for $7.1 billion — a move that led to ...

TimeTo and Cannes Lions have joined forces to offer guidance and education around sexual harassment at industry events ahead ...

Anat Ashkenazi will continue to serve in her role as CFO and as a member of Eli Lilly’s executive committee through the end ...

In April, in a 3-2 vote, the FTC approved a final rule prohibiting contracts that prevent an employee from taking a job with ...

A decade ago, the Food and Drug Administration (FDA) first approved Opdivo (nivolumab), BMS’ dual I-O drug that treats ...

Through the Protect the Gut Microbiome campaign, the two organizations are raising awareness about gut health and urging ...

Seymour has served as chief quality officer at Bristol Myers Squibb since October 2022, joining the company after a 20-year stint at Biogen.

Novo Nordisk, the pharmaceutical company behind Ozempic, has launched a national campaign promoting its injectable ...